Apollomics (APLM) Shares Outstanding (2020 - 2025)
Apollomics (APLM) posted quarterly Shares Outstanding (Entity) of $144.6 million for Q4 2025, up 41.76% year-on-year from $102.0 million in Q4 2024, and down 99.87% on a QoQ basis from $110.3 billion in Q2 2025.
Apollomics (APLM) Shares Outstanding (2020 - 2025) Analysis & Trends
Apollomics (APLM) has reported Shares Outstanding (Entity) for 6 consecutive years, with $144.6 million the latest figure, recorded in Q4 2025.
- Quarterly Shares Outstanding (Entity) rose 41.76% year-over-year to $144.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $144.6 million (up 41.76% YoY) and the FY2025 annual result came in at $144.6 million, up 41.76% from the prior year.
- Shares Outstanding (Entity) slipped to $144.6 million in Q4 2025 per APLM's latest filing, from $110.3 billion in the prior quarter.
- Over the last five years, Shares Outstanding (Entity) for APLM reached as high as $110.3 billion in Q2 2025 and fell as low as $3.9 million in Q2 2022.
- A 5-year average of $12.3 billion and a median of $54.5 million in 2022 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) sank 80.97% — and 2025, when it jumped 843374.67%.
- Year by year, Shares Outstanding (Entity) stood at $56.4 million in 2021, then retreated by 3.28% to $54.5 million in 2022, then plunged by 80.97% to $10.4 million in 2023, then surged by 882.55% to $102.0 million in 2024, then surged by 41.76% to $144.6 million in 2025.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $144.6 million, $110.3 billion, and $102.0 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 6,012.74 Bn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 47.82 Bn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.44 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 11.23 Bn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 254.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 400.00 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 62.19 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 198.10 Mn |
| 10 | Apollomics | 2.66 Bn | 2.66 Bn | - | 1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.45 Mn |
| Jun 30, 2025 | 1.10 Bn |
| Dec 31, 2024 | 1.02 Mn |
| Jun 30, 2024 | 937,400.00 |
| Dec 31, 2023 | 744,110.00 |
| Jun 30, 2023 | 590,000.00 |
| Dec 31, 2022 | 3.91 Mn |
| Jun 30, 2022 | 279,820.00 |
| Dec 31, 2021 | 4.04 Mn |
| Dec 31, 2020 | 3.61 Mn |